Ozoralizumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
Chemical and physical data | |
Formula | C1682H2608N472O538S12 |
Molar mass | 38.43 kg/mol |
![]() ![]() |
Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases.
Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. Ablynx has licensed the rights to the antibody in China to Eddingpharm.
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.